Medidata Diversity Program Named ‘Best of Show’ for Improving Equity in Clinical Trials at SCOPE Summit 2024
Novel, integrated Program enhances patient experience, accessibility, and inclusion of underrepresented groups in clinical research
New York – April 26, 2024 – Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, was honored with the Best of Show Award for the Medidata Diversity Program at the 15th annual Summit for Clinical Ops Executives (SCOPE). The Medidata Diversity Program, the industry’s most comprehensive solution for improving inclusivity in clinical trials, addresses common systemic and clinical barriers that can hinder a diverse range of individuals from participating in clinical trials.
By combining Medidata AI and Medidata Patient Cloud capabilities, the Program provides a unique multifaceted approach to building diversity into every step of the clinical trial process. The program improves patient access, awareness, and experiences through patient-centric solutions, infusing patient voices into protocol design and enabling the data-driven decision-making needed to execute the modern diversity action plans required for regulatory success.
“From choosing a research site to protocol design, embedding diversity throughout the clinical trial strategy is critical to ensuring medical advancements are inclusive and effective for all patient populations,” said Alicia Staley, vice president of patient engagement, Medidata. “Our industry-leading Program helps life sciences companies build studies that facilitate participation of minority groups, achieve representative clinical outcomes, and foster health equity.”
###
Contact:
Medidata PR
Analyst Relations